AAAAAA

   
Results: 1-21 |
Results: 21

Authors: HAMAGUCHI N TRUE TA GOETZ AS STOUFFER MJ LYBRAND TP JEFFS PW
Citation: N. Hamaguchi et al., ALPHA(1)-ADRENERGIC RECEPTOR SUBTYPE DETERMINANTS FOR 4-PIPERIDYL OXAZOLE ANTAGONISTS, Biochemistry, 37(16), 1998, pp. 5730-5737

Authors: FUKUDA K HAMAGUCHI N ODA T ISHIMATSU A MURAMATSU T
Citation: K. Fukuda et al., HEMAGGLUTINATING ACTIVITY OF EXTRACELLULAR ALKALINE METALLOENDOPEPTIDASES FROM VIBRIO SP. NUF-BPP1, Bioscience, biotechnology, and biochemistry, 62(6), 1998, pp. 1157-1160

Authors: CHANG JL JIN JP LOLLAR P BODE W BRANDSTETTER H HAMAGUCHI N STRAIGHT DL STAFFORD DW
Citation: Jl. Chang et al., CHANGING RESIDUE-338 IN HUMAN FACTOR-IX FROM ARGININE TO ALANINE CAUSES AN INCREASE IN CATALYTIC ACTIVITY, The Journal of biological chemistry, 273(20), 1998, pp. 12089-12094

Authors: CHANG YC SHEN MC HAMAGUCHI N RUF W LIN SW
Citation: Yc. Chang et al., ENGINEERED RECOMBINANT FACTOR-VII Q(217) VARIANTS WITH ALTERED INHIBITOR SPECIFICITIES, Thrombosis and haemostasis, 1997, pp. 2425-2425

Authors: YORIOKA N HAMAGUCHI N TANIGUCHI Y ASAKIMORI Y NISHIKI T ODA H YAMAKIDO M
Citation: N. Yorioka et al., GASTRIC ANTRAL VASCULAR ECTASIA IN A PATIENT ON HEMODIALYSIS IMPROVEDWITH CAPD, Peritoneal dialysis international, 16(2), 1996, pp. 177-178

Authors: HAMAGUCHI N TRUE TA SAUSSY DL JEFFS PW
Citation: N. Hamaguchi et al., PHENYLALANINE IN THE 2ND-MEMBRANE-SPANNING DOMAIN OF ALPHA(1A)-ADRENERGIC RECEPTOR DETERMINES SUBTYPE SELECTIVITY OF DIHYDROPYRIDINE ANTAGONISTS, Biochemistry, 35(45), 1996, pp. 14312-14317

Authors: WOLBERG AS LI LP CHEUNG WF HAMAGUCHI N PEDERSEN LG STAFFORD DW
Citation: As. Wolberg et al., CHARACTERIZATION OF GAMMA-CARBOXYGLUTAMIC ACID RESIDUE-21 OF HUMAN FACTOR-IX, Biochemistry, 35(32), 1996, pp. 10321-10327

Authors: OGAWA Y HAMAGUCHI N OHSHIMA K ITOH K
Citation: Y. Ogawa et al., HIGH-RESOLUTION ANALYSIS OF INDOOR MULTIPATH PROPAGATION STRUCTURE, IEICE transactions on communications, E78B(11), 1995, pp. 1450-1457

Authors: KAO PH HAMAGUCHI N LIN SR LIN SW
Citation: Ph. Kao et al., EXPRESSION OF FACTOR-IX-FACTOR-VII CHIMERA IN 293 CELLS, Thrombosis and haemostasis, 73(6), 1995, pp. 1204-1204

Authors: CHANG CW LIN CN SHEN MC HAMAGUCHI N LIN SW
Citation: Cw. Chang et al., CHARACTERIZATION OF FACTOR-IX(TAINAN) WITH A GLYCINE(48) TO ARGININE MUTATION, Thrombosis and haemostasis, 73(6), 1995, pp. 1206-1206

Authors: YORIOKA N OGAWA T OKUSHIN S ODA H TANIGUCHI Y HAMAGUCHI N HIRABAYASHI A SHIGEMOTO K YAMAKIDO H
Citation: N. Yorioka et al., STUDY OF THE EFFECTS OF PRAVASTATIN IN PATIENTS WITH GLOMERULONEPHRITIS ASSOCIATED WITH HYPERLIPIDEMIA, Current therapeutic research, 56(11), 1995, pp. 1210-1220

Authors: LIN SW CHANG CW HAMAGUCHI N LIN CN SMITH K SHEN MC
Citation: Sw. Lin et al., HEMOPHILIA-B WITH A MUTATION IN THE FIRST EGF-LIKE DOMAIN RESULTS IN DELAYED ACTIVATION BY THE FACTOR VIIA-TISSUE FACTOR COMPLEX, Blood, 86(10), 1995, pp. 1775-1775

Authors: SATO J HAMAGUCHI N DOKEN K GOTOH K OOTSU K IWASA S OGAWA Y TOGUCHI H
Citation: J. Sato et al., ENHANCEMENT OF THE ANTITUMOR-ACTIVITY OF RECOMBINANT INTERLEUKIN-2 (RIL-2) BY IMMUNOCOMPLEXING WITH AN F(AB')(2) FRAGMENT OF MURINE MONOCLONAL-ANTIBODY AGAINST RIL-2, Biological & pharmaceutical bulletin, 17(8), 1994, pp. 1101-1105

Authors: SATO J HAMAGUCHI N DOKEN K IWASA S OGAWA Y TOGUCHI H
Citation: J. Sato et al., PHARMACOKINETIC ALTERATION IN RATS OF RECOMBINANT INTERLEUKIN-2 (RIL-2) BY IMMUNOCOMPLEXING WITH A MONOCLONAL-ANTIBODY AGAINST RIL-2, Biological & pharmaceutical bulletin, 17(4), 1994, pp. 535-538

Authors: HAMAGUCHI N STAFFORD D
Citation: N. Hamaguchi et D. Stafford, IN-VITRO MUTAGENESIS STUDY OF 2 CRITICAL GLUTAMIC ACIDS IN THE CALCIUM-BINDING LOOP OF THE FACTOR-IX HEAVY-CHAIN, Thrombosis and haemostasis, 72(6), 1994, pp. 856-861

Authors: HAMAGUCHI N BAJAJ SP SMITH KJ STAFFORD DW
Citation: N. Hamaguchi et al., THE ROLE OF AMINO-TERMINAL RESIDUES OF THE HEAVY-CHAIN OF FACTOR IXA IN THE BINDING OF ITS COFACTOR, FACTOR VIIIA, Blood, 84(6), 1994, pp. 1837-1842

Authors: LIN SW LIN CN HAMAGUCHI N SMITH KJ SHEN MC
Citation: Sw. Lin et al., CHARACTERIZATION OF A FACTOR-IX VARIANT WITH A GLYCINE(207) TO GLUTAMIC-ACID MUTATION, Blood, 84(6), 1994, pp. 1866-1873

Authors: SATO J HAMAGUCHI N DOKEN K GOTOH K OOTSU K IWASA S OGAWA Y TOGUCHI H
Citation: J. Sato et al., ENHANCEMENT OF ANTITUMOR-ACTIVITY OF RECOMBINANT INTERLEUKIN-2 (RIL-2) BY IMMUNOCOMPLEXING WITH A MONOCLONAL-ANTIBODY AGAINST RIL-2, Biotherapy, 6(3), 1993, pp. 225-231

Authors: WOLBERG AS CHEUNG WF STAFFORD DW HAMAGUCHI N
Citation: As. Wolberg et al., CHARACTERIZATION OF THE FUNCTIONAL ROLES OF GAMMA-CARBOXYGLUTAMIC ACID (GLA) RESIDUES-20 AND RESIDUE-21 IN HUMAN FACTOR-IX, Thrombosis and haemostasis, 69(6), 1993, pp. 614-614

Authors: LIN SW LIN CN SHEN MC SMITH KJ HAMAGUCHI N LAO YL
Citation: Sw. Lin et al., CHARACTERIZATION OF A FACTOR-IX VARIANT WITH A GLYCINE(207) TO GLUTAMIC-ACID MUTATION, Thrombosis and haemostasis, 69(6), 1993, pp. 616-616

Authors: HAMAGUCHI N ROBERTS H STAFFORD DW
Citation: N. Hamaguchi et al., MUTATIONS IN THE CATALYTIC DOMAIN OF FACTOR-IX THAT ARE RELATED TO THE SUBCLASS HEMOPHILIA BM, Biochemistry, 32(25), 1993, pp. 6324-6329
Risultati: 1-21 |